Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age group between 30 to 60 years Newely diagnosed cases of Type 2 DM and known Type 2 DM patient only on Metformin 500 mg OD Non insulin dependent diabetes mellitus Patient with fasting blood sugar between 126 - 200 mg dl and post prandial blood sugar between 140 - 350 mg dl Patient having HbA1C between 6.5 10 Patient taking Metformin 500 mg with Diet Restrictions
Exclusion criteria
Exclusion criteria: CRITERIA FOR EXCLUSION Juvenile Diabetes and Insulin Dependent Diabetes Mellitus IDDM Patients with Renal Disorders like Chronic kidney disease and Acute kidney diseases Patients with acute complications Hyperglycemic & hypoglycemic coma Ketoacidosis and related complication and Infections like gangrene Patients with chronic diabetic complications like Nephropathy Neuropathy and Retinopathy Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study and evaluate the add on effect of Chandraprabhavati 500 MG OD with Metformin 500 MG OD in Prameha Type ll DM for 3 months. Timepoint: BSL F and PP will be assessed after entry point 7 th 15 th 30th 60th day and end of the trial 90th Day HBA1C will assessed on Day 1 & Day 90 th of Trial | — |
Secondary
| Measure | Time frame |
|---|---|
| To observe adverse effects if anyTimepoint: Follow up on 1st week 4 th week & 12 th week | — |
Countries
India
Contacts
Shiva Trusts Yashwantrao Chavan Ayurvedic Medical College And Hospital Chhatrapati Sambhajinagar